1. Home
  2. UBX vs PWM Comparison

UBX vs PWM Comparison

Compare UBX & PWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • PWM
  • Stock Information
  • Founded
  • UBX 2009
  • PWM 2018
  • Country
  • UBX United States
  • PWM Hong Kong
  • Employees
  • UBX N/A
  • PWM N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • PWM
  • Sector
  • UBX Health Care
  • PWM
  • Exchange
  • UBX Nasdaq
  • PWM Nasdaq
  • Market Cap
  • UBX 36.9M
  • PWM 34.6M
  • IPO Year
  • UBX 2018
  • PWM 2023
  • Fundamental
  • Price
  • UBX $1.94
  • PWM $0.70
  • Analyst Decision
  • UBX Strong Buy
  • PWM
  • Analyst Count
  • UBX 2
  • PWM 0
  • Target Price
  • UBX $7.00
  • PWM N/A
  • AVG Volume (30 Days)
  • UBX 203.3K
  • PWM 1.3M
  • Earning Date
  • UBX 04-14-2025
  • PWM 02-13-2025
  • Dividend Yield
  • UBX N/A
  • PWM N/A
  • EPS Growth
  • UBX N/A
  • PWM N/A
  • EPS
  • UBX N/A
  • PWM N/A
  • Revenue
  • UBX N/A
  • PWM $639,912.00
  • Revenue This Year
  • UBX N/A
  • PWM N/A
  • Revenue Next Year
  • UBX $33.62
  • PWM N/A
  • P/E Ratio
  • UBX N/A
  • PWM N/A
  • Revenue Growth
  • UBX N/A
  • PWM N/A
  • 52 Week Low
  • UBX $0.94
  • PWM $0.45
  • 52 Week High
  • UBX $3.10
  • PWM $2.70
  • Technical
  • Relative Strength Index (RSI)
  • UBX 48.69
  • PWM 36.58
  • Support Level
  • UBX $1.99
  • PWM $0.50
  • Resistance Level
  • UBX $2.17
  • PWM $1.27
  • Average True Range (ATR)
  • UBX 0.22
  • PWM 0.35
  • MACD
  • UBX -0.05
  • PWM -0.07
  • Stochastic Oscillator
  • UBX 22.41
  • PWM 11.07

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About PWM Prestige Wealth Inc.

Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.

Share on Social Networks: